Moxonidine Rises Ramp Up In August
Pricewatch UK – August 2020
Moxonidine topped our table of Biggest Risers for the second month in a row, as UK prices that had doubled in July accelerated even more rapidly in August.
You may also be interested in...
Moxonidine led the price rises for established generics in the UK in July, with averages for the hypertension treatment more than doubling in some cases. However, among recently-launched products, rasagiline stood out with an average that was more than three times that of the previous month.
Exemestane led the steepest price rises for generics seen in the UK in May. However, concession pricing for the breast cancer drug overestimated the actual prices in the market recorded by WaveData.
Erythromycin and paracetamol were among the products with the steepest price rises in the UK in April, as the coronavirus pandemic continued to make its effects felt in the generics market.